RT Journal Article
SR Electronic
T1 Gut microbiota may underlie the predisposition of healthy individuals to COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.22.20076091
DO 10.1101/2020.04.22.20076091
A1 Gou, Wanglong
A1 Fu, Yuanqing
A1 Yue, Liang
A1 Chen, Geng-dong
A1 Cai, Xue
A1 Shuai, Menglei
A1 Xu, Fengzhe
A1 Yi, Xiao
A1 Chen, Hao
A1 Zhu, Yi
A1 Xiao, Mian-li
A1 Jiang, Zengliang
A1 Miao, Zelei
A1 Xiao, Congmei
A1 Shen, Bo
A1 Wu, Xiaomai
A1 Zhao, Haihong
A1 Ling, Wenhua
A1 Wang, Jun
A1 Chen, Yu-ming
A1 Guo, Tiannan
A1 Zheng, Ju-Sheng
YR 2020
UL http://medrxiv.org/content/early/2020/04/25/2020.04.22.20076091.abstract
AB The COVID-19 pandemic is spreading globally with high disparity in the susceptibility of the disease severity. Identification of the key underlying factors for this disparity is highly warranted. Here we describe constructing a proteomic risk score based on 20 blood proteomic biomarkers which predict the progression to severe COVID-19. We demonstrate that in our own cohort of 990 individuals without infection, this proteomic risk score is positively associated with proinflammatory cytokines mainly among older, but not younger, individuals. We further discovered that a core set of gut microbiota could accurately predict the above proteomic biomarkers among 301 individuals using a machine learning model, and that these gut microbiota features are highly correlated with proinflammatory cytokines in another set of 366 individuals. Fecal metabolomic analysis suggested potential amino acid-related pathways linking gut microbiota to inflammation. This study suggests that gut microbiota may underlie the predisposition of normal individuals to severe COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Natural Science Foundation of China (81903316, 81773416, 81972492, 21904107, 81672086), Zhejiang Ten-thousand Talents Program (101396522001), Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars (LR19C050001), the 5010 Program for Clinical Researches (2007032) of the Sun Yat-sen University, Hangzhou Agriculture and Society Advancement Program (20190101A04), and Tencent foundation (2020). The funder had no role in study design, data collection and analysis, decision to publish, or writing of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw data of 16 S rRNA gene sequences are available at CNSA (https://db.cngb.org/cnsa/) of CNGBdb at accession number CNP0000829. https://db.cngb.org/cnsa/